600 completed, 136 unknown, 121 recruiting, 81 terminated. 188 Phase 3, 166 Not applicable, 112 Phase 2, 109 Phase 4, 34 Phase 1.
Follow Thromboembolism: new trials by email Literature Review of Thromboembolism trials Research Report on Thromboembolism
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety And Field Evaluation of Plasma Lyophilized for Acute and Surgical Management Applications Freeze-Dried Plasma, Conventional Plasma - Thromboembolic Event, FDP | Phase 4 | Not yet recruiting | Teleflex | 867 | 2027-10-01 | 2026-09-30 |
| A Study to Observe the Pattern of Use and Safety of Rivaroxaban in Children Under 2 Years Old With Venous Thromboembolism (VTE) Rivaroxaban (Xarelto, BAY59-7939), Standard of care (SOC) - Venous Thromboembolism, Children Under 2 Years | Not yet recruiting | Bayer | 850 | 2027-09-01 | 2026-10-02 | |
| Collaborative Risk-stratified Investigation in Thrombosis-prone Inpatients With Critical Illness: Anticoagulation With LMWH in Teens for ThromboProphylaxis (CRITICAL-Teens-TP). Enoxaparin - Venous Thromboembolism (VTE) | Phase 3 | Not yet recruiting | Johns Hopkins All Children's Hospital | 802 | 2027-04-15 | 2026-05-26 |
| Recurrent or Persistent Device Related Thrombus After Left Atrial Appendage Occlusion: The RE-DRT Study Percutaneous Left Atrial Appendage Occlusion (LAAO), Device-related Thrombus (DRT) | Not yet recruiting | Institut universitaire de cardiologie et de pneumologie de Québec, University Laval | 100 | 2026-12-01 | 2026-03-24 | |
| Edoxaban Versus Apixaban in Cancer-Associated Venous Thromboembolism edoxaban, Apixaban - Venous Thromboembolism, Active Cancer | Phase 4 | Not yet recruiting | Samsung Medical Center | 2300 | 2026-11-01 | 2026-10-01 |
| TOF-MRV Versus Post-Contrast 3D T1 MRI in Dural Venous Sinus Thrombosis Cerebral Thrombosis, Venous Thrombosis | Not yet recruiting | Assiut University | 80 | 2026-10-20 | 2026-10-22 | |
| Comparison of Thrombin Generation, Platelet Activation and Aggregation Profiles in Patients With Sickle Cell Disease Depending on Their SS or SC Genotype (DrepAgreg) Sickle Cell Disease, Venous Thromboembolism | Not yet recruiting | Centre Hospitalier Universitaire de la Guadeloupe | 60 | 2026-10-15 | 2026-10-01 | |
| Vortosiran for VTE Prevention Vortosiran, Placebo - Venous Thromboembolism (VTE), Cancer | Phase 2 | Not yet recruiting | Ribocure Pharmaceuticals AB | 150 | 2026-10-01 | 2026-09-30 |
| Comparison of DOACs and LMWH for Thromboprophylaxis After Total Knee Arthroplasty Apixaban, Rivaroxaban, Enoxaparin (LMWH) - Total Knee Arthroplasty, Venous Thromboembolism | Not applicable | Recruiting | Military Hospital of Tunis | 138 | 2026-09-15 | 2026-10-16 |
| TicAgreLor Versus Placebo to Prevent Cerebral ISCHemia in anEuRysmal Low Grade SAH A Double Blinded Randomised Controlled Study Experimental group: ticagrelor, Control group: placebo - Subarachnoid Hemorrhage, Aneurysmal, Brain Ischemia | Phase 3 | Not yet recruiting | University Hospital, Toulouse | 274 | 2026-09-14 | 2026-09-15 |
| Venous Thromboembolism (VTE) Prophylaxis With REGN7508 and REGN9933 in Adult and Adolescent Participants With a Peripherally Inserted Central Catheter (PICC) REGN7508, REGN9933, Placebo - Venous Thromboembolism (VTE) | Phase 3 | Recruiting | Regeneron Pharmaceuticals | 1908 | 2026-09-07 | 2026-09-29 |
| Risk Factors of Venous Thrombotic Event in Interstitial Lung Disease Interstitial Lung Disease, Venous Thromboembolism | Not yet recruiting | Sohag University | 100 | 2026-09-01 | 2026-09-22 | |
| Decision Aid for Anticoagulation Duration After Unprovoked Venous Thromboembolism DECIDE-VTE Patient Decision Aid - Venous Thromboembolism (VTE), Deep Vein Thrombosis (DVT) | Not applicable | Not yet recruiting | McGill University Health Centre/Research Institute of the McGill University Health Centre | 850 | 2026-09-01 | 2026-06-24 |
| Glycoprotein IIb/IIIa PET/CT in Various GPIIb/IIIa-Related Disease 18F/68Ga-GP1 - Thrombi, Thrombus, Brain | Recruiting | Tianjin Medical University | 500 | 2026-09-01 | 2026-09-10 | |
| Circadian Variation of Anti-Factor Xa in Hospitalized Trauma Patients Circadian Variation in Anti-Factor Xa (Anti-FXa) Activity | Recruiting | The University of Texas Health Science Center, Houston | 40 | 2026-08-26 | 2026-10-02 | |
| Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hematologic Cancers REGN7508, Apixaban - Venous Thromboembolism (VTE) | Phase 3 | Recruiting | Regeneron Pharmaceuticals | 1600 | 2026-08-26 | 2026-10-21 |
| Smart Technology Facilitated Patient-centered Care for Patients With Pulmonary Thromboembolism mobile venous thromboembolism application (mVTEA) - Venous Thromboembolism, Pulmonary Thromboembolisms | Not applicable | Recruiting | Navy General Hospital, Beijing | 2972 | 2026-08-20 | 2026-09-09 |
| Focused Ultrasound of the Popliteal Fossa for Detection of Symptomatic Baker's Cysts in Patients With Suspected Deep Vein Thrombosis: A Pilot Diagnostic Accuracy Study Index Test (Focused Ultrasound of the Popliteal Fossa), Reference test (Routine DVT Diagnostic Pathway) - Baker's Cyst | Completed | Aarhus University Hospital | 94 | 2026-08-03 | 2026-10-28 | |
| Extended Prophylactic Anticoagulation Following Spinal Surgery for Metastatic Disease Apixaban - Venous Thromboembolism (VTE), Deep Vein Thrombosis (DVT) | Phase 4 | Not yet recruiting | James Bayley | 50 | 2026-08-01 | 2026-07-20 |
| The OAT Trail: The Obesity Anti-Coagulation Thromboprophylaxis Trial. Anti-Xa Activity Monitoring, Tinzaparin (Leo), enoxaparin - Bariatric Surgery, Anti-Xa Activity | Not applicable | Not yet recruiting | University College Dublin | 180 | 2026-08-01 | 2026-05-18 |
Showing 20 of 1025. Sign in to see all of them.
Venous Thromboembolism (696) · Venous Thrombosis (217) · Pulmonary Embolism (206) · Thrombosis (103) · Atrial Fibrillation (73) · Neoplasms (67) · Hemorrhage (60) · Stroke (55) · Intracranial Thrombosis (46) · Cardiovascular Diseases (34) · COVID-19 (27) · Intracranial Embolism (21) · Ischemic Stroke (20) · Myocardial Infarction (19)
Vascular Diseases (1012) · Embolism and Thrombosis (1008) · Cardiovascular Diseases (991) · Respiratory Tract Diseases (251) · Pathological Conditions, Signs and Symptoms (250) · Lung Diseases (244) · Pathologic Processes (231) · Embolism (203) · Thrombosis (192) · Nervous System Diseases (162) · Central Nervous System Diseases (145) · Brain Diseases (139) · Cerebrovascular Disorders (127) · Heart Diseases (112)
Rivaroxaban (112) · Enoxaparin (108) · apixaban (70) · Warfarin (57) · Dalteparin (41) · Dabigatran (40) · Aspirin (37) · Heparin, Low-Molecular-Weight (33) · edoxaban (25) · Tinzaparin (24) · Fondaparinux (23) · Heparin (22) · enoxaparin sodium (19) · Standard of Care (14) · Blood Specimen Collection (12)
Bayer (46) · Boehringer Ingelheim (28) · Ottawa Hospital Research Institute (22) · University Hospital, Brest (20) · Brigham and Women's Hospital (16) · McMaster University (15) · GlaxoSmithKline (14) · Sanofi (14) · University of Utah (14) · Bristol-Myers Squibb (11) · Insel Gruppe AG, University Hospital Bern (11) · Astellas Pharma Inc (10) · Daiichi Sankyo (9) · Pfizer (9) · Assistance Publique - Hôpitaux de Paris (8)
United States (295) · France (153) · Canada (151) · Germany (100) · Italy (100) · China (92) · Spain (82) · Netherlands (78) · United Kingdom (77) · Denmark (68) · Russia (63) · Sweden (62) · Switzerland (59) · Belgium (56) · Austria (55)
Sam Schulman, MD, PhD (5) · Christopher Puccini, MD (4) · Shirley Wang, PhD, ScM (4) · Takeshi Fuji (4) · Alexander Turpie, MD (3) · Benilde Cosmi, MD (3)
PMID 33337539, PMID 33779986, PMID 24081972, PMID 33086312, PMID 35244208, PMID 22429800, PMID 22709460, PMID 27807306, PMID 28762617, PMID 31420317, PMID 32657973, PMID 33502773, PMID 34172290, PMID 34597414, PMID 34622445, PMID 34878173, PMID 15319720, PMID 18190818, PMID 22863355, PMID 22995531, PMID 23425163, PMID 24251360, PMID 24344086, PMID 26578849, PMID 27980462, PMID 28063245, PMID 28617144, PMID 29452956, PMID 29649055, PMID 31867054, PMID 31975354, PMID 34755519, PMID 35389229, PMID 35876829, PMID 36150047, PMID 36413425, PMID 38348778, PMID 38844941, PMID 39238110, PMID 39968829, PMID 40163217, PMID 40302153, PMID 41218619, PMID 10453824, PMID 10499070, PMID 10546719, PMID 11867132, PMID 11982463, PMID 12083490, PMID 12131409
2014 (9), 2023 (7), 2016 (6), 2015 (5), 2025 (5), 2005 (4), 2009 (4), 2017 (4), 2008 (3), 2018 (3), 2019 (3), 2004 (2), K23HL132054 (2), K23HL112908 (1), P30CA015083 (1)